Amide proton transfer could be a surrogate imaging marker for predicting vascular cognitive impairment.

导出 LinkOut

翻译打印收藏纠错

第一作者： Ronghua,Mu

第一单位： Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, 541004 Guilin, China.

作者： Ronghua,Mu ^[1] ; Xiaoyan,Qin ^[1] ; Wei,Zheng ^[1] ; Peng,Yang ^[1] ; Bingqin,Huang ^[2] ; Xin,Li ^[1] ; Fuzhen,Liu ^[1] ; Kan,Deng ^[3] ; Xiqi,Zhu ^[4]

作者单位： Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, 541004 Guilin, China. ^[1] Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, 541004 Guilin, China; Graduate School, Guilin Medical University, 541002 Guilin, China. ^[2] Philips (China) Investment Co., Ltd., Guangzhou Branch, 510000 Guangzhou, China. ^[3] Department of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, 541004 Guilin, China. Electronic address: xiqi.zhu@163.com. ^[4]

关键词 Amide proton transfer Cerebral small vessel disease Mild cognitive impairment Vascular cognitive impairment Vascular dementia

主题词人类(Humans);男(雄)性(Male);中年人(Middle Aged);质子(Protons);神经变性疾病(Neurodegenerative Diseases);酰胺类(Amides);痴呆, 血管性(Dementia, Vascular)

DOI 10.1016/j.brainresbull.2023.110793

PMID 37863439

发布时间 2024-11-04

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交